Actionable news
All posts from Actionable news
Actionable news in ARGS: ARGOS THERAPEUTICS Inc,

3 Buy-Ranked Healthcare Stocks Building Momentum Now

Earnings season is well underway, and there are many companies whose positive earnings results will lead their share prices to surge higher. Success can be attained by buying shares in companies that are positioned to surpass earnings expectations.

This isn't easy to do under normal circumstances. However, our Zacks Rank does a great job at finding candidates that are likely to beat our earnings consensus estimate. Today, we've found three healthcare companies that appear to be building momentum as they head into their earnings reports.

Each of these companies has seen double digit share price gains in the last month, but I'm talking about a different kind of momentum that these companies have been building. These healthcare corporations have seen earnings estimates trend higher over the last 30 days. As our EPS consensus trends higher, so does the possibility of a stock surpassing the broader expectations of the market.

Innoviva Inc- INVA

Innoviva develops, commercializes, and manages biopharmaceuticals. It is also a Zacks Rank #2 (Buy). The company has a portfolio of respiratory assets partnered with GlaxoSmithKline GSK . In the last month, Innoviva shares have surged 16.57% higher. The company doles out a generous 3.64% dividend to investors.

This year, Innoviva's earnings and sales are projected to grow by 466.25% and 138.53% respectively...